Evidence map›Paper›PMID 29430228›Full record

ArticleCase reports in gastroenterology

Routine Treatment-Resistant

Jan K Adamski, Björn B Jäschke, Raija S Uusitalo-Seppälä, Kalle V J Moilanen, Antti V Pehkonen, Wojciech Weigl

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Nonthyroidal Illness Syndrome inJournal of global infectious diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jan K AdamskiDepartment of Anaesthesiology and Intensive Care, Satakunta Central Hospital, Pori, Finland.
Björn B JäschkeDepartment of Anaesthesiology and Intensive Care, Satakunta Central Hospital, Pori, Finland.
Raija S Uusitalo-SeppäläDepartment of Infectious Diseases, Satakunta Central Hospital, Pori, Finland.
Kalle V J MoilanenDepartment of Gastroenterology, Satakunta Central Hospital, Pori, Finland.
Antti V PehkonenDepartment of Anaesthesiology and Intensive Care, Satakunta Central Hospital, Pori, Finland.
Wojciech WeiglAnaesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Akademiska Hospital, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of the extreme form of hypothyroidism defined as myxedema is very rare. Acute symptoms and their management have been described in detail previously. However, not much attention has been devoted to therapeutic challenges that are faced in the recovery phase of the treatment, especially pertaining to the gastrointestinal system. The link between myxedema and the appearance of severe

Indexed as

Clostridial infectionClostridium difficileEnterocolitisFecal microbiotaHypothyroidismMyxedemaThyroid insufficiencyTransplantation

Identifiers

PMID29430228
PMCPMC5803723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.